Clinical Trial Update: VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of Telaprevir on ECG readings in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED